The last quarter of the year is, according to stock market history, the most fruitful for investors and although there has been a clear reversal this year compared to what has happened historically, the truth is that, If tradition is fulfilled, we are clearly in the most bullish part of the stock markets in 2025.
Starting from that premise, we wanted to get closer to the values that, technically speaking, present the best outlook at this time. And especially, although we have up to 13 Ibex 35 values with technical perfection at this moment, according to Premium Indicators prepared by Investment Strategieswith the historical highs in hand, we are going to look at the last ones that have reached this condition. For example, Indra, the most bullish value on the stock market and the best in recent times, is already expensive for the majority of the market with its particular rally. So we are left with those who in October have become values of ’10’ per technician.
Solaria
We are talking about a value with advances of 92% so far this year, but the year was beginning, and we saw it pass for a good part of it, with few pretensions in the market. De facto, the photovoltaic company hIt had gone through a negative ordeal in its balance in the last three years and only 9% in the last two.
Thus, its stock market takeoff, after the April lows exceeding 6.17 euros, occurred since June, in an irregular evolution but clearly rising to exceed 14 euros in August to fall back to 10 euros per title at the end of September. from there the Glory, with maximums included above 15.52, in the middle of this month.
And so we arrive at its current situation, with levels of technical perfection, very strong both in the medium and long term, since last October 13. A newcomer to this classification, which remains in an upward process, despite last week’s brake, with the potential to overcome its resistance.
His great handicap, his downward bets continue to be of great caliber: although they have been sharply cut from just over 10% to the current 2.93%, they remain high and were partially renewed in October.
Rovi Laboratories
The pharmaceutical company has so far lagged behind the bullish drive and highs marked by the Ibex 35 so far this year. But the truth is that it has accelerated significantly in the last month, with increases of 13%, which in the quarter also become a double-digit upward impulse.
And the best thing is that it has turned the value bullish so far this year, leaving the last positions of the selective.
Furthermore, according to the premium indicators of Ei, Rovi reaches a very strong level, both in the medium and long term since last October 16, therefore, it returns to the levels lost at the beginning of last month, the best of the year.
The impetus comes above all from the endorsement of third-party investors in its business. First in its agreement with Novo Nordiskto produce medicines for the Danish pharmacy from 2026 and second with Roche, since both will collaborate to produce a new drug in development from the Swiss company’s metabolic and cardiovascular portfolio.
Naturgy (Gas Natural)
It is another of the values that is among the best of the best by technician within the Ibex 35 in the month of October among the premium Strategies indicators. Very strong in the medium and long term, with resistance breaking operations and purchases at supports. And risk of accumulation of excesses and bearish figures.
It also returns to those levels, lost since last September 5, with an upward trajectory so far this year, although somewhat lower than the average recorded by the Ibex 35 in advances. With maximums that it has not managed to surpass, since the beginning of August, and with results that it has just published that are on track for a record.
It earns 1,668 million euros until the month of September, 6% more, while confirming its goal of exceeding 2,000 million of euros at the end of the year. Ebitda stood at 4,214 million euros, in line with the record levels obtained in the same period of the previous year.
Sacyr
This is a new value in technical perfection in this month of October: very strong both in the medium and long term and with annual advances somewhat below those of the Ibex 35, although with great upward progression in the last month, of 13%.
From IG they highlight that, «for an investor with a medium-long horizon, Sacyr appears as an interesting option within the infrastructure sector: international exposure, long-term contracts, risk relatively mitigated by concessional nature. But it is important to remember that these types of companies require patience and tolerance to the cycle.»
Concessions continue to be its great progression. It has just been selected in Chile to be awarded the construction and operation of a 20 kilometer highway in the Biobío Region, a project that has a budget of around 330 million euros.
In addition, it is bidding in its largest market, which is Italy, for the largest toll in the country, of 10,000 million between Brenner and Modena.
Activate Renewable Energies
Technical perfection, with very strong both in the medium and long term, for Acciona energy, the 90% subsidiary of Acciona in green energywhich has gained double-digit traction in the last month and up 42% so far this year, beating the Spanish selectivewhile just reaching those levels.
Factors such as falling interest rates on both sides of the Atlantic have boosted its stock market improvement along with lower tariff pressure, with the idea of meeting its objectives for the current year, which pass to achieve an Ebitda of 1,000 million euros, similar to that of 2024.
A boost that also comes this week from the hand of Nordex, Acciona’s German subsidiary, with 47% of its capital skyrocketing above 21% after improving its forecasts for the current year, establishing Ebitda margin guides of between 7.5 and 8.5% and expected sales of between 7,400 and 7,900 million euros.